By Madison Muller | BloombergEli Lilly & Co. shares surged after its experimental pill helped patients shed weight and control blood sugar...

A HEALTHCARE worker has insisted Mounjaro has been “life-changing” after she shed five stone in seven months.Connie Bulloch, from Cambus...

Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive...

FROM sulphur burps to diarrhoea, we’re all familiar with the brutal side effects of fat jabs – but have you heard of ‘Ozempic feet’? Oze...

Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive...

Those who fondly remember cartoonist Bill Watterson’s late, lamented comic strip, “Calvin and Hobbes” will probably also recall that the fav...

Amy Schumer is getting real about her experience with weight loss meds — and giving fans a huge laugh in the process.In a video shared to Ti...

ASHLEY James has just been on a jaunt to Mexico. Her trip to Tulum looked amazing – pristine white sands, turquoise waters and Ashley he...

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said he is considering a “regulatory framework” for Medicare and Medicaid to...

WeightWatchers is reportedly gearing up to file for bankruptcy.According to an in-depth report from The Wall Street Journal, WW Internationa...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medic...

Ozempic may be living up to its reputation as a miracle drug.If you’re not familiar with the GLP-1 agonist, Ozempic was first approved in 20...

The Danish pharmaceutical company behind obesity drug Wegovy, Novo Nordisk, plans to invest US$1.09bn in expanding its facility in Minas Ger...

The Centers for Medicare and Medicaid Services recently announced—without explanation—that it would not proceed with a proposal initiated by...

By SUSAN HAIGH and MARC LEVY, Associated PressStates increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, O...